Cargando…
Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
Integrin Alpha v Beta 6 is expressed primarily in solid epithelial tumors, such as cholangiocarcinoma, pancreatic cancer, and colorectal cancer. It has been considered a potential and promising molecular marker for the early diagnosis and treatment of cancer. Cholangiocarcinoma and pancreatic ductal...
Autores principales: | Lian, Yunyu, Zeng, Silue, Wen, Sai, Zhao, Xingyang, Fang, Chihua, Zeng, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395192/ https://www.ncbi.nlm.nih.gov/pubmed/37525872 http://dx.doi.org/10.1177/15330338231189399 |
Ejemplares similares
-
The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer
por: Hargadon, Kristian M., et al.
Publicado: (2023) -
The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?
por: Zhang, Naibin, et al.
Publicado: (2023) -
Perioperative control of paroxysmal hypertension using esmolol with alpha-blockade in a child with a germline mutated paraganglioma
por: Babiker, Amir, et al.
Publicado: (2021) -
Identification of a novel hepatocyte nuclear factor-1 alpha (HNF1A) variant in maturity onset diabetes of the young type 3 (HNF1A-MODY)
por: Verma, Megha, et al.
Publicado: (2022) -
Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials
por: Llovet, Josep M., et al.
Publicado: (2022)